Fatigue in patients with chronic obstructive pulmonary disease: Protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study

BMJ Open

Volumn 8, Issue 4, 2018, Pages

  Goërtz, Yvonne M J ^a   Looijmans, Milou ^b   Prins, Judith B ^b   Janssen, Daisy J A ^a,c   Thong, Melissa S Y ^d   Peters, Jeannette B ^b   Burtin, Chris ^e   Meertens Kerris, Yvonne ^f   Coors, Arnold ^b   Muris, Jean W M ^g   Sprangers, Mirjam A G ^d   Wouters, Emiel F M ^a,c   Vercoulen, Jan H ^b   Spruit, Martijn A ^a,c,e,h  

^a CIRO Center of Expertise for Chronic Organ Failure   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e HASSELT UNIVERSITY   (Belgium)

^f Centre of Expertise for Chronic Organ Failure   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

chronic obstructive pulmonary disease; fatigue; underlying factors

Indexed keywords

ALL CAUSE MORTALITY; ARTICLE; BEHAVIOR; CHECKLIST; CHECKLIST INDIVIDUAL STRENGTH FATIGUE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; DISEASE EXACERBATION; ECOLOGICAL MOMENTARY ASSESSMENT; FATIGUE; FUNCTIONAL STATUS ASSESSMENT; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PHYSICAL PERFORMANCE; PSYCHOLOGICAL ASPECT; AGED; BELGIUM; COMPLICATION; FORCED EXPIRATORY VOLUME; HAND STRENGTH; NETHERLANDS; QUALITY OF LIFE;

AGED; BELGIUM; DISEASE PROGRESSION; FATIGUE; FORCED EXPIRATORY VOLUME; HAND STRENGTH; HUMANS; NETHERLANDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 85055119140     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2018-021745     Document Type: Article

References (61)

1. Janson-Bjerklie S, Carrieri VK, Hudes M. The sensations of pulmonary dyspnea. Nurs Res 1986;35:154-1619.
2. Kapella MC, Larson JL, Patel MK, et al. Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res 2006;55:10-17.
3. Stridsman C, Skär L, Hedman L, et al. Fatigue affects health status and predicts mortality among subjects with COPD: report from the population-based OLIN COPD study. COPD 2015;12:199-206.
4. Peters JB, Heijdra YF, Daudey L, et al. Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status. Patient Educ Couns 2011;85:281-5.
5. Baghai-Ravary R, Quint JK, Goldring JJ, et al. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 2009;103:216-23.
6. Janssen DJ, Spruit MA, Uszko-Lencer NH, et al. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med 2011;14:735-43.
7. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13.
8. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
9. Spruit MA, Vercoulen JH, Sprangers MAG, et al. Fatigue in COPD: an important yet ignored symptom. Lancet Respir Med 2017;5:542-4.
10. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117(Suppl 2):398S-401.
11. Inal-Ince D, Savci S, Saglam M, et al. Fatigue and multidimensional disease severity in chronic obstructive pulmonary disease. Multidiscip Respir Med 2010;5:162-7.
12. Lewko A, Bidgood PL, Garrod R. Evaluation of psychological and physiological predictors of fatigue in patients with COPD. BMC Pulm Med 2009;9:47.
13. Woo K. A pilot study to examine the relationships of dyspnoea, physical activity and fatigue in patients with chronic obstructive pulmonary disease. J Clin Nurs 2000;9:526-33.
14. Breukink SO, Strijbos JH, Koorn M, et al. Relationship between subjective fatigue and physiological variables in patients with chronic obstructive pulmonary disease. Respir Med 1998;92:676-82.
15. Hanania NA, Müllerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011;183:604-11.
16. Al-shair K, Kolsum U, Dockry R, et al. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011;12:3.
17. Kentson M, Tödt K, Skargren E, et al. Factors associated with experience of fatigue, and functional limitations due to fatigue in patients with stable COPD. Ther Adv Respir Dis 2016;10:410-24.
18. Postma DS, Wijkstra PJ, Hiemstra PS, et al. The Dutch national program for respiratory research. Lancet Respir Med 2016;4:356-7.
19. From the Global Strategy fort he diagnosis, management and prevention of COPD, global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www. goldcopd. org/ (accessed 27 Oct 2017).
20. Metsemakers JF, Höppener P, Knottnerus JA, et al. Computerized health information in The Netherlands: a registration network of family practices. Br J Gen Pract 1992;42:102-6.
21. Vercoulen JH, Swanink CM, Fennis JF, et al. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994;38:383-92.
22. Beurskens AJ, Bültmann U, Kant I, et al. Fatigue among working people: validity of a questionnaire measure. Occup Environ Med 2000;57:353-7.
23. Bültmann U, de Vries M, Beurskens AJ, et al. Measurement of prolonged fatigue in the working population: determination of a cutoff point for the checklist individual strength. J Occup Health Psychol 2000;5:411-6.
24. Worm-Smeitink M, Gielissen M, Bloot L, et al. The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength. J Psychosom Res 2017;98:40-6.
25. Repping-Wuts H, Fransen J, van Achterberg T, et al. Persistent severe fatigue in patients with rheumatoid arthritis. J Clin Nurs 2007;16-377-83.
26. Servaes P, Gielissen MF, Verhagen S, et al. The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psychooncology 2007;16:787-95.
27. Vercoulen JH, Daudey L, Molema J, et al. An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). Int J Behav Med 2008;15:263-79.
28. Maes IH, Delespaul PA, Peters ML, et al. Measuring health-related quality of life by experiences: the experience sampling method. Value Health 2015;18:44-51.
29. Larson RWC M. The experience sampling method. New directions for naturalistic methods in the behavioral sciences. San Francisco: Jossey-Bass, 1983.
30. Faul F, Erdfelder E, Lang AG, et al. GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91.
31. Gelman A, Hill J. Multilevel power calculation using fake-data simulation: data analysis using regression and multilevel/hierarchical models. New York: Cambridge University Press, 2007.
32. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b2393.
33. Collins LM, Lanza ST. Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences: John Wiley & Sons, 2013.
34. Andrykowski MA, Aarts MJ, van de Poll-Franse LV, et al. Low socioeconomic status and mental health outcomes in colorectal cancer survivors: disadvantage? advantage or both? Psychooncology 2013;22:2462-9.
35. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
36. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983;16:87-101.
37. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.
38. Schols AM, Wouters EF, Soeters PB, et al. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991;53:421-4.
39. Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1428-46.
40. Bernabeu-Mora R, Medina-Mirapeix F, Llamazares-Herrán E, et al. The short physical performance battery is a discriminative tool for identifying patients with COPD at risk of disability. Int J Chron Obstruct Pulmon Dis 2015;10:2619-26.
41. Bohannon RW, Andrews AW. Interrater reliability of hand-held dynamometry. Phys Ther 1987;67:931-3.
42. Bechtol CO, test G. Grip test; the use of a dynamometer with adjustable handle spacings. J Bone Joint Surg Am 1954;36-A-820-4.
43. Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012;126:2890-909.
44. Houben-Wilke S, Jörres RA, Bals R, et al. Peripheral artery disease and its clinical relevance in patients with chronic obstructive pulmonary disease in the copd and systemic consequencescomorbidities network study. Am J Respir Crit Care Med 2017;195:189-97.
45. De Boever P, Louwies T, Provost E, et al. Fundus photography as a convenient tool to study microvascular responses to cardiovascular disease risk factors in epidemiological studies. J Vis Exp 2014;92:e51904.
46. Peters JB, Daudey L, Heijdra YF, et al. Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument. Qual Life Res 2009;18:901-12.
47. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727-36.
48. Spinhoven P, Ormel J, Sloekers PP, et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997;27:363-70.
49. Villeneuve S, Pepin V, Rahayel S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest 2012;142:1516-23.
50. Gielissen MF, Knoop H, Servaes P, et al. Differences in the experience of fatigue in patients and healthy controls: patients' descriptions. Health Qual Life Outcomes 2007;5:36.
51. Boer LM, Daudey L, Peters JB, et al. Assessing the stages of the grieving process in chronic obstructive pulmonary disease (COPD): validation of the Acceptance of Disease and Impairments Questionnaire (ADIQ). Int J Behav Med 2014;21:561-70.
52. Vercoulen JH, Swanink CM, Galama JM, et al. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998;45:507-17.
53. Jacobsen PB, Andrykowski MA, Thors CL. Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol 2004;72:355-61.
54. Kwakkenbos L, van den Hoogen FH, Custers J, et al. Validity of the fear of progression questionnaire-short form in patients with systemic sclerosis. Arthritis Care Res 2012;64:930-4.
55. Hibbard JH, Mahoney ER, Stockard J, et al. Development and testing of a short form of the patient activation measure. Health Serv Res 2005;40:1918-30.
56. Rabinovich RA, Louvaris Z, Raste Y, et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013;42:1205-15.
57. Buysse DJ, Reynolds CF, Monk TH, et alThe Pittsburgh Sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
58. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
59. Servaes P, Verhagen S, Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 2002;13:589-98.
60. Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
61. Sonderen E. Het meten van sociale steun met de Sociale Steun Lijst-Interacties (SSLI-I) en de Sociale Steun Lijst-Discrepancies (SSL-D), een handleiding [Assessing social support with the Social Support List-Interactions (SSL-I) and the social support list-discrepancies, a manual]. Noordelijk Centrum voor Gezondheidsvraagstukken 1993.